Among peptide hormones, agonistic analogs of GnRH and somatostatin can inhibit tumor growth [48], while in other cases, such as with α -MSH, only antagonists can evoke tumor growth inhibition in an autocrine/paracrine manner. This evidence concerns the gene GNRH1 and neoplasm.